Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B ; volume:13 ; number:1 ; day:9 ; month:6 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (9.6.2023), 1-8, 12.2023
- Urheber
-
Oh, Joo Hyun
Park, Yewan
Goh, Myung Ji
Sinn, Dong Hyun
Ahn, Sang Bong
Kang, Wonseok
Gwak, Geum-Youn
Paik, Yong-Han
Choi, Moon Seok
Lee, Joon Hyeok
Paik, Seung Woon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-36668-2
- URN
-
urn:nbn:de:101:1-2023091908560453254058
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oh, Joo Hyun
- Park, Yewan
- Goh, Myung Ji
- Sinn, Dong Hyun
- Ahn, Sang Bong
- Kang, Wonseok
- Gwak, Geum-Youn
- Paik, Yong-Han
- Choi, Moon Seok
- Lee, Joon Hyeok
- Paik, Seung Woon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients
Role of serum micro-RNA 486-5p in Egyptian cirrhotic hepatitis C patients with hepatocellular carcinoma
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Evaluation of fibrosis in cirrhotic elderly patients with HCC
Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma
A Hepatitis C Virus-Associated Cirrhotic Patient Developing Interstitial Pneumonia during the Course of Antiviral Therapy with Ombitasvir/Paritaprevir/Ritonavir
Antiviral drugs against hepatitis C virus
Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma
Serum Beclin 1 and autophagy-related protein-5 and the risk of hepatocellular carcinoma among cirrhotic hepatitis C patients
Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients
Role of serum micro-RNA 486-5p in Egyptian cirrhotic hepatitis C patients with hepatocellular carcinoma
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Evaluation of fibrosis in cirrhotic elderly patients with HCC
Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma
A Hepatitis C Virus-Associated Cirrhotic Patient Developing Interstitial Pneumonia during the Course of Antiviral Therapy with Ombitasvir/Paritaprevir/Ritonavir
Antiviral drugs against hepatitis C virus
Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma
Serum Beclin 1 and autophagy-related protein-5 and the risk of hepatocellular carcinoma among cirrhotic hepatitis C patients
Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients
Role of serum micro-RNA 486-5p in Egyptian cirrhotic hepatitis C patients with hepatocellular carcinoma
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Evaluation of fibrosis in cirrhotic elderly patients with HCC
Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma
A Hepatitis C Virus-Associated Cirrhotic Patient Developing Interstitial Pneumonia during the Course of Antiviral Therapy with Ombitasvir/Paritaprevir/Ritonavir
Antiviral drugs against hepatitis C virus
Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma